CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
CSPC Innovation Pharmaceutical Co Ltd
Revenue
CSPC Innovation Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Revenue
¥2.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Revenue
¥31.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
See Also
What is CSPC Innovation Pharmaceutical Co Ltd's Revenue?
Revenue
2.5B
CNY
Based on the financial report for Dec 31, 2023, CSPC Innovation Pharmaceutical Co Ltd's Revenue amounts to 2.5B CNY.
What is CSPC Innovation Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
15%
Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for CSPC Innovation Pharmaceutical Co Ltd have been 24% over the past three years , 15% over the past five years .